U.K., Italian Citizens File Lawsuit Against Bayer Over Blood-Clotting Products Allegedly Made With HIV-Contaminated Blood
April 26, 2005
Several dozen British and Italian citizens on Friday filed a lawsuit in the District Court of Northern Illinois against the U.S. unit of Bayer and five other pharmaceutical companies, alleging that the companies knowingly sold blood-clotting products that could have been tainted with blood containing HIV and hepatitis C, the Chicago Sun-Times reports. The suit -- filed against Bayer, Baxter Healthcare, Armour Pharmaceutical, Alpha Therapeutic, the Aventis Behring unit of Aventis and Immuno-US -- names as plaintiffs several dozen people who claim they or a deceased relative contracted HIV or hepatitis C from Factor VIII or Factor IX concentrates, blood products that can stop potentially fatal bleeding in people with hemophilia. The plaintiffs are seeking $75,000 and a jury trial to address charges of fraudulent omission and concealment, wrongful death and negligence. Representatives from Baxter declined to comment on Friday, and representatives from the other companies could not be reached, according to the Sun-Times (Thomas, Chicago Sun-Times, 4/25).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Aspen Pharmacare in Agreement With Gilead to Produce Antiretroviral Drugs for Sale in 95 Developing Countries
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.